Back to Search
Start Over
BMP-2 releasing mineral-coated microparticle-integrated hydrogel system for enhanced bone regeneration.
- Source :
-
Frontiers in bioengineering and biotechnology [Front Bioeng Biotechnol] 2023 Aug 10; Vol. 11, pp. 1217335. Date of Electronic Publication: 2023 Aug 10 (Print Publication: 2023). - Publication Year :
- 2023
-
Abstract
- Introduction: Large bone defects (LBD) caused by trauma, infection, and tumor resection remain a significant clinical challenge. Although therapeutic agents such as bone morphogenetic protein-2 (BMP-2), have shown substantial potency in various clinical scenarios, their uncontrollable release kinetics has raised considerable concern from the clinical viewpoint. Mineral-coated microparticle (MCM) has shown its excellent biologics loading and delivery potential due to its superior protein-binding capacity and controllable degradation behaviors; thus, it is conceivable that MCM can be combined with hydrogel systems to enable optimized BMP-2 delivery for LBD healing. Methods: Herein, BMP-2 was immobilized on MCMs via electrostatic interaction between its side chains with the coating surface. Subsequently, MCM@BMP-2 is anchored into a hydrogel by the crosslinking of chitosan (CS) and polyethylene glycol (PEG). Results and Discussion: This microparticle-hydrogel system exhibits good biocompatibility, excellent vascularization, and the sustained release of BMP-2 in the bone defect. Furthermore, it is observed that this microsphere-hydrogel system accelerates bone formation by promoting the expression of osteogenesis-related proteins such as RUNX2, osteopontin, and osteocalcin in bone marrow mesenchymal stem cells (BMSCs). Thus, this newly developed multifunctional microparticle-hydrogel system with vascularization, osteogenesis, and sustained release of growth factor demonstrates an effective therapeutic strategy toward LBD.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2023 Xu, Luo, Chen, Chen, Yu and Ye.)
Details
- Language :
- English
- ISSN :
- 2296-4185
- Volume :
- 11
- Database :
- MEDLINE
- Journal :
- Frontiers in bioengineering and biotechnology
- Publication Type :
- Academic Journal
- Accession number :
- 37635994
- Full Text :
- https://doi.org/10.3389/fbioe.2023.1217335